MYO News and Press, Myomo Inc. From 08/21/19

Goal of Business Development Program is to Expand Access of Company’s Product Line to Additional Country Markets Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for t...

Myomo, Inc. (MYO) Q2 2019 Results Conference Call August 8, 2019 4:30 PM ET Company Participants Vivian Cervantes – Investor Relations Paul Gudonis – Chairman and Chief Executive Officer Dave Henry – Chief Financial Officer Conference Call Participants ...

Myomo (NYSEMKT: MYO ): Q2 GAAP EPS of -$0.15 beats by $0.01 . More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Record Quarterly Revenues and 28% Sequential Expansion of Reimbursement Pipeline Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological dis...

Management to hold a conference call at 4:30 p.m. EDT August 1, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders...

Myomo ® , Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, was recently a featured presenter at the United Br...

Over 50 screening days planned in six countries Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, a...

Shipping First Devices for Patients in Germany and Denmark Growing Pipeline of MyoPro Units in International Markets Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionalit...

Myomo to Attend with Ryzur Medical to Assess Chinese Market Opportunity Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders an...

Myomo (NYSEMKT: MYO ): Q1 GAAP EPS of -$0.17 beats by $0.02 . More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...